Abingworth’s Molecular Templates, Inc. MTEM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
$66K Hold
13,333
0.02% 18
2022
Q3
$150K Hold
13,333
0.05% 17
2022
Q2
$182K Hold
13,333
0.06% 18
2022
Q1
$690K Hold
13,333
0.2% 16
2021
Q4
$780K Hold
13,333
0.19% 17
2021
Q3
$1.34M Hold
13,333
0.3% 17
2021
Q2
$1.56M Hold
13,333
0.48% 15
2021
Q1
$2.51M Hold
13,333
0.87% 12
2020
Q4
$1.88M Hold
13,333
0.64% 12
2020
Q3
$2.18M Hold
13,333
0.47% 12
2020
Q2
$2.76M Hold
13,333
0.77% 12
2020
Q1
$2.64M Hold
13,333
1.75% 10
2019
Q4
$2.8M Buy
+13,333
New +$1.92M 1.35% 9

Other funds holding MTEM

Abingworth's MTEM Position: Q4 2022 in Review

Abingworth held its Molecular Templates, Inc. (MTEM) position steady in Q4 2022 at 13,333 shares worth $66K. The position accounts for 0.02% of the portfolio, ranked #18.

Abingworth first reported a position in MTEM in Q4 2019 and has held it in 13 quarters since. The position peaked at $2.8M in Q4 2019. 50 funds tracked by Wall St. Rank hold MTEM as of Q4 2022.

  • Abingworth held 13,333 shares of Molecular Templates, Inc. worth $66K as of Q4 2022.
  • Abingworth left its Molecular Templates, Inc. share count unchanged in Q4 2022.
  • Molecular Templates, Inc. made up 0.02% of Abingworth's portfolio in Q4 2022, its #18 holding.
  • Abingworth first reported a position in Molecular Templates, Inc. in Q4 2019 and has held it in 13 quarters since.
  • Abingworth's Molecular Templates, Inc. position peaked at $2.8M in Q4 2019.
  • 50 funds tracked by Wall St. Rank held Molecular Templates, Inc. as of Q4 2022.

Based on Abingworth's 13F filing for Q4 2022, filed 10 Feb 2023.